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Contrasting Roles of the IL-1 and IL-18 Receptors in
MyD88-Dependent Contact Hypersensitivity
Paul A. Klekotka1,4, Liping Yang2 and Wayne M. Yokoyama2,3
Contact hypersensitivity (CHS) requires activation of the innate immune system, and results in an adaptive
immune response. Many cells of the innate immune system use Toll-like receptors (TLRs), which signal through
the adaptor protein, MyD88, to initiate an immune response. MyD88 is also required for signaling downstream
of the IL-1 and Il-18 receptors (IL-1R and IL-18R, respectively). Herein, we studied the MyD88 signaling pathway
in the CHS response to DNFB. Mice deficient in MyD88 were unable to mount a CHS response to DNFB. In
contrast, mice deficient in Toll/IL-1R-containing adaptor-inducing IFN-b, TLR2, TLR4, TLR6, and TLR9 had no
defect in their ability to respond to DNFB. Although both IL-1R and IL-18R-deficient mice showed a reduced
CHS response to DNFB, in bone marrow chimera and adoptive transfer experiments, we found that MyD88 and
the IL-18R were required in a radioresistant cell in the sensitization phase of the CHS response. In contrast,
similar strategies revealed that the IL-1R was required in a radiosensitive cell in the sensitization phase of the
CHS response. Taken together, these data indicate that the IL-1R and IL-18R/MyD88 pathways are required in
distinctly different cells during the sensitization phase of CHS.
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INTRODUCTION
Contact hypersensitivity (CHS) is clinically manifested as
allergic contact dermatitis, and is a common dermatological
problem causing occupational and physical disability
(Holness and Nethercott, 1995; Belsito, 1999). The CHS
response is also used experimentally as a model of a delayed-
type hypersensitivity response. It is initiated by members of
the innate immune system, such as keratinocytes (KCs) and
dendritic cells (DCs), and results in an adaptive immune
response that is mediated by IFN-g-producing T cells
(Watanabe et al., 2002). Moreover, several proinflammatory
cytokines have been implicated in the CHS response, and
provide an important link between the innate and adaptive
immune systems in control of CHS (Shornick et al., 1996;
Wang et al., 2002).
The innate immune system is armed with several pattern
recognition proteins, such as the Toll-like receptors (TLRs),
which serve to alert the organism to external threats and to
initiate an immune response. Signaling through the TLRs in
response to external stimuli activates the innate immune
system and influences the subsequent response of the
adaptive immune system (Kaisho and Akira, 2006). Numer-
ous TLRs are expressed on innate immune cells in the skin.
TLRs 3,4,5, and 9 are expressed on human KCs (Lebre et al.,
2007), whereas other TLRs are expressed on the DCs and
circulating lymphocytes (Kaisho and Akira, 2006). Recent
studies found a defect in the CHS response in mice that
lacked TLR4 in combination with loss of either TLR2 or the
IL-12 receptor b2 (Martin et al., 2008).
All members of the TLR family signal through the adaptor
protein, MyD88, except for TLR3, which signals through
another signaling adapter, Toll/IL-1 receptor (IL-1R)-contain-
ing adaptor-inducing IFN-b (TRIF) (Kaisho and Akira, 2006).
After TLR stimulation, mice deficient in MyD88 do not
produce a proinflammatory response (Adachi et al., 1998;
Schnare et al., 2001). However, MyD88 is also an adaptor
protein critical for signaling through the IL-1 and IL-18
receptors (IL-1R and IL-18R, respectively). Indeed, MyD88/
mice have a loss of IL-1 and IL-18-mediated functions
(Adachi et al., 1998), and they are also susceptible to
multiple infections, and this phenotype is dependent on
signaling downstream of the cytokine receptors (Adachi et al.,
1998; Baratin et al., 2005).
IL-1 has been shown to have a crucial role in the CHS
response (Shornick et al., 1996; Wang et al., 2002). IL-1a is
produced by multiple members of the innate immune system
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in the skin, such as KCs (Kupper et al., 1986) and cutaneous
DCs, including Langerhans cells (LCs) (Sauder et al., 1984).
IL-1a is required for T-cell activation during the sensitization
phase of CHS (Nakae et al., 2001). IL-1b is produced by
activated macrophages and KCs (March et al., 1985;
Husmann et al., 1996). During the elicitation phase of the
CHS response, IL-1b is required to induce tumor necrosis
factor-a production and the subsequent inflammatory cell
infiltrate (Nakae et al., 2003). The IL-1R is expressed on
multiple cells in the CHS response, including LCs, T cells,
and B cells (Wang et al., 1999). It is unknown what role, if
any, MyD88 has downstream of the IL-1R in the CHS
response.
IL-18 is produced by activated DCs, LCs, and macro-
phages (Stoll et al., 1998; Wang et al., 2002). IL-18 acts as a
costimulatory molecule with IL-12 in the development of the
Th1 phenotype (Micallef et al., 1996), and it stimulates the
development of cytotoxic T cells from naı¨ve CD8þ T cells
(Okamoto et al., 1999). In the skin, the IL-18 receptor (IL-18R)
is expressed on LCs, DCs, KCs, and endothelial cells. During
the CHS response, LCs migrate to the skin-draining lymph
node (LN) in response to hapten challenge in an IL-18-
dependent manner (Wang et al., 2002; Antonopoulos et al.,
2008). In addition, the LCs produce IL-18 in the draining LN
during the sensitization phase, and this is important for
subsequent IFN-g and tumor necrosis factor-a production
during the CHS response (Wang et al., 2002; Antonopoulos
et al., 2008). Although the role of IL-18 has been studied in
the CHS response, the importance of MyD88 downstream of
the IL-18R in the CHS response has not been demonstrated.
As the IL-1R, IL-18R, and most TLRs signal through
MyD88, we used MyD88-deficient mice to study the role of
these receptors in the CHS response. We found that MyD88-
deficient mice were unable to mount a CHS response,
whereas TLR2, 4, 6, and 9-deficient mice had a normal CHS
response. Using bone marrow (BM) chimeras and adoptive
transfer experiments, we found that both MyD88 and the
IL-18R were required on a radioresistant cell in the
sensitization phase. In contrast, the IL-1R was required on a
radiosensitive cell in the sensitization phase. Our results
demonstrate that the crucial roles of IL-1, IL-18, and MyD88
at the interface of the innate and adoptive immune systems
during the CHS response is mediated through different cell
populations.
RESULTS
CHS is MyD88-dependent, but TRIF- and TLR2-, 4-, 6-, and
9-independent
To begin to examine the role of the TLR and IL-1 signaling
pathways in the CHS response, we studied MyD88/ mice
in the C57BL/6 genetic background, which had a profound
defect in their ability to mount a CHS response (Figure 1a)
that remained less than that seen in C57BL/6 for at least
72 hours (data not shown). By contrast, TRIF-deficient mice
had no defect in their CHS response to DNFB (Figure 1a). As
TLR3 is the only known MyD88-independent TLR and it
depends on TRIF (Kaisho and Akira, 2006), these results
indicate that TLR3 is not involved in the CHS response. TLR4
can signal through both MyD88-dependent and -independent
(TRIF-dependent) pathways, but the CHS response to DNFB is
intact in TLR4-deficient mice (Supplementary Figure S1)
demonstrating that TLR4 itself does not account for the defect
in the CHS response in MyD88/ mice. To evaluate the
possibility that the defect in CHS in the MyD88/ mice was
due to a defect in signaling through another TLR, we
measured the CHS response in TLR-deficient mice that were
available to us in the C57BL/6 genetic background. TLR2, 6,
or 9-deficient mice did not demonstrate a significant defect in
the CHS response to DNFB (Supplementary Figure S1). Taken
together, these data indicate that the CHS response is
MyD88-dependent, and independent of TRIF, TLR2, 3, 4, 6,
and 9.
CHS is IL-1 and IL-18-dependent
To investigate whether a defect in IL-1 and/or IL-18 signaling
could explain the loss of CHS response in MyD88/ mice,
we studied IL-1R/ and IL-18R/ mice. There was a defect
in the CHS response in both IL-1R and IL-18R-deficient mice
(Figure 1b). These results using IL-1R and IL-18R knockout
mice corroborate the results of previous studies using IL-1b-
deficient and IL-18-deficient mice. (Shornick et al., 1996;
Antonopoulos et al., 2008).
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Figure 1. Contact hypersensitivity is MyD88-, IL-1R-, and IL-18R dependent.
(a) Hapten-specific ear swelling was measured 24 hours after challenge with
DNFB in B6, MyD88-, and TRIF-deficient mice. Results represent mean±SEM
(n¼4) from one of two or more separate experiments. Statistical significance
as compared with B6 is indicated as n.s.¼not significant, *P¼ 0.0002.
(b) Hapten-specific ear swelling was measured 24 hours after challenge with
DNFB in B6, IL-1R-, IL-18R-, and MyD88-deficient mice. Results represent
mean±SEM (n¼4) from one of two or more separate experiments. n.s.¼ not
significant, *Po0.02.
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Requirement for MyD88, IL-1, and IL-18 in different cells in the
CHS response
To further study the role of MyD88, IL-1, and IL-18 in the
CHS response, we performed CHS experiments on BM
chimeras. Wild type (WT) C57BL/6 mice congenic for Ly5.1
were lethally irradiated and reconstituted with BM cells
from Ly5.2 mice that were either WT or MyD88/ on the
C57BL/6 genetic background. Analysis of chimerism showed
that roughly 485% of the T cells and 495% of the B cells,
NK cells, and neutrophils were donor derived (Supplemen-
tary Figure S2 and Supplementary Table S1). After 6 weeks,
the chimeric mice were sensitized to DNFB and then
challenged 5 days later. As expected, Ly5.1 mice reconsti-
tuted with WT BM were able to mediate a robust CHS
response (Figure 2a). Surprisingly, WT Ly5.1 mice reconsti-
tuted with MyD88-deficient BM also exhibited a robust CHS
response. Conversely, when WT Ly5.1 BM cells were used to
reconstitute either Ly5.2 WT or MyD88/ lethally irradiated
mice, WT Ly5.1 donors were able to mount a CHS response
in the WT host, but not in the MyD88/ host (Figure 2a).
Taken together, these data demonstrate that MyD88 is
required in radioresistant, host-derived cells but not in the
BM donor-derived cells to mediate the CHS response.
To determine whether the IL-1R is required in a similar
manner as MyD88 in the CHS response, BM chimeras were
created using IL-1R-deficient mice. The extent of chimerism
was similar to those described above (Supplementary Table
S1). Surprisingly, WT Ly5.1 donor BM cells were able to
reconstitute the CHS response in IL-1R/ mice (Figure 2b).
However, IL-1R/ BM-derived cells were less able to
support a CHS response in WT Ly5.1 mice. Thus, in contrast
to the results with MyD88, these results demonstrate that the
IL-1R is required on a BM-derived cell during the CHS
response.
We also examined the role of IL-18 in the CHS response in
BM chimeras with IL-18R-deficient mice (Supplementary
Table S1). BM cells from WT Ly5.1 mice were able to
reconstitute the CHS response in WT animals, but not in
IL-18R/ mice, whereas IL-18R-deficient BM cells were able
to reconstitute the CHS response in WT Ly5.1 mice (Figure
2c). Thus, these results were similar to those found using
MyD88-deficient mice, indicating that both MyD88 and
IL-18R are required in host-derived radioresistant cells to
mediate CHS, in contrast to the requirement for IL-1R on
donor-derived radiosensitive BM cells.
MyD88, IL-18R, and IL-1R are required for the sensitization
phase of the CHS response
Regardless of the cell involved, the requirement for MyD88,
IL-18R, and IL-1R during the CHS response could be in either
the sensitization or elicitation phase of the CHS response.
To address this issue, we first performed adoptive transfer
experiments using DNFB-sensitized WT LN cells transferred
to naı¨ve WT and MyD88/ mice. In these experiments, LN
cells from sensitized WT mice were injected into naı¨ve WT or
MyD88/ mice and then challenged with DNFB. DNFB-
sensitized WT LN cells were capable of transferring a CHS
response to both WT and MyD88/ mice (Figure 3a). In
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Figure 2. MyD88 and IL-18R are required in radioresistant host-derived cells in
the contact hypersensitivity response, whereas IL-1R is required in radiosensitive
bone marrow-derived cells. (a) C57BL/6 mice congenic for Ly5.1 (5.1) were
lethally irradiated and reconstituted with BM cells from mice that were either
B6 or MyD88/. After 6 weeks, the mice were sensitized and challenged
with DNFB. The plots represent the hapten-specific ear swelling 24 hours after
challenge with DNFB of each mouse relative to the response in B6 mice.
Results represent the mean±SEM (n¼4) of the response relative to B6 from
one of two or more separate experiments. To determine the relative response,
the hapten-specific response in B6 mice from each experiment was set to
100%, and the hapten-specific response of each bone marrow transplanted
mouse was normalized to B6 and plotted as percent of B6. Statistical
significance was determined from the individual experiments before
normalization to B6. n.s.¼not significant, *Po0.01. (b) BM cells from wild
type (WT) Ly5.1 (5.1) mice were used to reconstitute lethally irradiated WT B6
or IL-1R/ mice (5.14B6 or 5.14IL-1R/, respectively). In addition, BM
cells from mice that were either B6 or IL-1R/ were used to reconstitute
lethally irradiated WT Ly5.1 (5.1) mice (B645.1 or IL-1R/45.1,
respectively). (c) BM cells from mice that were from WT Ly5.1 (5.1) mice were
used to reconstitute lethally irradiated WT B6 or IL-18R/ mice (5.14B6 or
5.14IL-18R/, respectively). In addition, B6 or IL-18R/ BM was used to
reconstitute lethally irradiated WT Ly5.1 (5.1) mice (B645.1 or IL-18R/
45.1, respectively). After 6 weeks, the mice were sensitized and challenged
with DNFB. The plots for (b) and (c) represent the hapten-specific ear swelling
24 hours after challenge with DNFB. Results represent mean±SEM (n¼4)
from one of two or more separate experiments. Statistical significance as
compared with B6 is indicated as n.s.¼ not significant, *Po0.001.
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contrast, LN cells from sensitized MyD88/ mice were
unable to transfer a CHS response to naı¨ve WT mice (Figure
3a). These data demonstrate that MyD88 is required during
the sensitization phase of the CHS response.
We used adoptive transfer studies to similarly determine
what aspect of the CHS response required the IL-18R and
IL-1R. DNFB-sensitized WT LN cells were capable of
transferring a CHS response to WT, IL-18R/, and IL-1R/
mice (Figures 3b and c). In the reverse experiment, LN cells
from sensitized IL-18R/ and IL-1R/ mice were unable to
transfer a CHS response to naı¨ve WT mice (Figure 3b and c).
These findings are consistent with the results from IL-1 and
IL-18 cytokine-deficient mice, and demonstrate a role for
these cytokines in the sensitization phase of the CHS
response (Shornick et al., 1996; Antonopoulos et al., 2008).
Thus, these results demonstrate that the IL-18R and the IL-1R,
similar to MyD88, are required in cells involved in the
sensitization phase of the CHS response.
DC activation in MyD88, IL-1R-, and IL-18R-deficient mice
As our results demonstrate that MyD88 is required in a
radioresistant cell type during the sensitization phase, we
sought to determine the characteristics of this cell. Epidermal
LCs are a radioresistant DC population in the epidermis that
migrate from the skin in response to cutaneously applied
haptens, but their role in the CHS response is unclear
(Banchereau and Steinman, 1998; Antonopoulos et al., 2008;
Fukunaga et al., 2008; Merad et al., 2008). In addition, there
is evidence that as many as 20–25% of the dermal DCs
remain host derived after BM transplantation (Bogunovic
et al., 2006; Shklovskaya et al., 2008). This led us to evaluate
the DCs in the skin-draining LNs after sensitization with
DNFB.
First, we performed time course experiments to analyze
the number of DCs (MHC-IIhigh, CD11cþ cells) in the skin-
draining LNs after a single application of DNFB. At baseline,
naı¨ve WT mice had 2.1±0.9104 DCs and 2.4±0.6106
total cells. Naı¨ve MyD88/ mice had 1.7±0.2 104 DCs
and 2.0±0.4 106 total cells. In the experiments, there was a
smaller increase in the number of DCs 48 hours after
sensitization with DNFB in MyD88/ (2.0±0.4104)
versus WT (3.9±0.7 104) mice (Po0.05). There was also
a smaller increase in the total cell number in the LN at
48 hours in the MyD88/ (2.4±0.4106) versus WT
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Figure 3. MyD88, the IL-18R, and the IL-1R are required in the sensitization phase of the contact hypersensitivity response. (a) Wild type (WT) mice were
sensitized with DNFB (dWT) and 5 days later the lymphocytes from their skin-draining lymph nodes were injected into naı¨ve WT (WT) or naı¨ve
MyD88/ (MyD88) mice (dWT4WT or dWT4MyD88, respectively). In the converse experiment, lymphocytes from the skin-draining lymph nodes of DNFB-
sensitized WT (dWT) or MyD88/ (dMyD88) mice were injected into naı¨ve WT (WT) mice (dWT4WT or dMyD884WT, respectively). After
the injection of the lymphocytes, the mice were challenged with DNFB and the hapten-specific response was measured 24 hours later. The results are depicted
as the relative response to B6, as described in Figure 2a. The plots represent the mean±SEM (n¼ 4) of the response relative to B6 from one of two or more
separate experiments. Statistical significance was determined from the individual experiments before normalization to B6. n.s.¼ not significant, * Po0.05.
(b) WT or IL-18R/ mice were sensitized with DNFB (dWT or dIL-18R/) and 5 days later the lymphocytes from their skin-draining lymph nodes were
injected into either naı¨ve WT (nWT) or naı¨ve IL-18R/ (nIL-18R/) mice. (c) In similar experiments, lymphocytes from the skin-draining lymph nodes
of DNFB-sensitized WT (dWT) or IL-1R/ (dIL-1R/) mice were injected into either naı¨ve WT (nWT) or naı¨ve IL-1R/ (nIL-1R/) mice. After injection
of the lymphocytes, the mice were challenged with DNFB and the hapten-specific response was measured 24 hours later. The results in b and c are depicted as
the mean±SEM (n¼4) from one of two or more separate experiments. Statistical significance as compared with dWT4nWT is indicated as n.s.¼ not significant,
and *Po0.002. The difference between WT and dWT4nWT, dWT4nIL-18R/, or dWT4nIL-1R/ was not significant (P40.05).
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(4.2±0.3106) mice (Po0.01). The percentage of DCs was
similar at this time point for both the MyD88/ and WT
mice, hence it is likely that the decrease in DC number is a
result of the decrease in total cell number in the LN. In
addition, these differences were resolved by 72 hours after
sensitization.
Next, we evaluated the activation status of the DCs in the
skin-draining LN over a 4-day period by FACS using CD86
expression as a marker of DC activation (Larsen et al., 1992).
In these experiments, maximal CD86 expression was found
72 hours after a single application of DNFB in sensitized WT
mice (Figure 4a). CD86 expression on DCs from naı¨ve
MyD88/ mice was comparable with naı¨ve WT mice, but
DCs from MyD88/ mice failed to upregulate CD86
expression after sensitization with DNFB (Figure 4a). These
results suggested that the defect in the CHS response seen in
the MyD88/-deficient mice was from a defect in DC
activation.
To extend these findings, we examined DC activation in
both IL-1R/ and IL-18R/ mice 72 hours after sensitization
with DNFB. Surprisingly, DCs from both IL-1R/ and
IL-18R/ mice expressed high levels of CD86 after
sensitization, comparable with DC from sensitized WT mice
(Figure 4b). Therefore, the defect in CD86 expression in the
MyD88/ mice is not likely to be the cause of the defect in
the sensitization phase of the CHS response, because we
would expect the same defect in the IL-18R/ mice.
DISCUSSION
Allergic contact dermatitis is a significant dermatological
problem, modeled by CHS in mice. Herein, we demonstrate
that MyD88 is required in the CHS response, independent of
TLRs 2, 4, 6, and 9. It is also TLR3-independent, as TRIF-
deficient mice have an intact CHS response. These findings
are consistent with recent findings that the CHS response is
defective in mice that lacked both TLR-4 and the IL-12Rb2
(Martin et al., 2008). Moreover, the loss of a single TLR may
not be sufficient to abrogate the CHS response. Regardless,
MyD88 also delivers signals from both the IL-1R and IL-18R,
and both IL-1 and IL-18 have been implicated in the CHS
response (Shornick et al., 1996; Wang et al., 2002;
Antonopoulos et al., 2008). Herein, we found that the IL-1R
is required in a radiosensitive, BM-derived cell, and surpris-
ingly, signaling downstream of the IL-1R is not dependent on
MyD88. By contrast, the IL-18R and MyD88 are required in a
radioresistant, non-BM-derived cell type involved in the
sensitization phase of the CHS response. Thus, IL-1R and
IL-18R are required on different cells in the CHS response.
The identity of the radioresistant cell that requires the
IL-18R and MyD88 in the sensitization phase is unclear.
Epidermal LCs are a major DC population in the epidermis
(Banchereau and Steinman, 1998) that are radioresistant,
express Langerin and the IL-18R, and migrate from the skin in
response to IL-18 (Antonopoulos et al., 2008). However,
studies using Langerin knockout mice and mice conditionally
deficient in Langerin suggest that epidermal LCs have a
limited role in antigen presentation in CHS (Merad et al.,
2008). The antigen-presenting cell in the skin during the CHS
response is likely a DC from the dermis (Merad et al., 2008).
We therefore evaluated the activation status of MHC-IIhigh,
CD11cþ DCs (epidermal LCs are included in this population)
in the skin-draining LNs and found a defect in CD86
expression in the MyD88/ mice, but not in the IL-18R/
or IL-1R/ mice. We also found that the DCs that
upregulated CD86 expression were Langerin negative (PAK
and WMY, unpublished results), suggesting that the CD86high
DCs were neither the epidermal LCs nor the Langerinþ
dermal DCs (Merad et al., 2008). These results suggest that
CD86 is upregulated on a DC population from the skin or the
LN in a MyD88-dependent manner.
It is not clear what role these CD86high DCs have in the
sensitization phase of the CHS response. As the CD86high
expression is not dependent on the presence of the IL-18R, it
suggests that this MyD88-dependent pathway is separate
from the one that is defective in the MyD88/ and IL-18R/
mice during the sensitization phase. Future studies may
examine the characteristics of these CD86high DCs. In
addition, our studies cannot exclude a role for epidermal
LCs or Langerinþ DCs in the sensitization phase of the CHS
response.
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Figure 4. CD86 expression on dendritic cells from skin-draining lymph
nodes. (a) Wild type (WT), MyD88/, (b) IL-1R/, and IL-18R/ mice were
sensitized on the abdomen with a single dose of DNFB. Three days later the
lymphocytes were removed from the skin-draining lymph nodes and analyzed
by FACS. The dendritic cells were gated as CD11cþ , MHC-IIhigh cells and
plotted as a histogram showing CD86 expression. Dendritic cells from DNFB-
treated mice are plotted as solid lines and naı¨ve mice of the same genotype
are plotted as dashed lines. The irrelevant antibody is shown in the gray
histogram. The results from vehicle-treated mice are similar to those of the
naı¨ve mice and are omitted for clarity. The results are representative from
three or more experiments.
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Regardless, there are several other possible cell types in
the skin that may require MyD88 and IL-18R during the
sensitization phase of the CHS response. The IL-18R is
expressed on multiple cell types in the skin, including on KCs
and endothelial cells (Dinarello, 1999). The IL-18R on KCs
may be required to initiate or propagate a cytokine loop
necessary to initiate the sensitization phase of the CHS
response. For example, DNFB may activate the inflamma-
some in KCs that results in the processing and secretion of
IL-1b and IL-18 (Sutterwala et al., 2006; Watanabe et al.,
2007). This secreted IL-18 may then act on KCs or other skin-
resident cells to initiate the CHS response. Alternatively, the
IL-18R and/or MyD88 may be required in endothelial cells or
perhaps LN stromal cells for proper trafficking of DCs and/or
lymphoid cells during the sensitization phase. Our results
suggest that this possibility may partially contribute to CHS,
because MyD88/ mice have decreased total cell number
and DC number in the skin-draining LNs 48 hours after
sensitization with DNFB. An additional possibility, which
cannot be formally excluded, is that MyD88 and the IL-18R
are required in different cells in the same pathway during the
CHS response.
The results from the BM chimeras demonstrate that
MyD88/ and IL-18R/ lymphocytes can be sensitized
and mount a CHS response. On the other hand, our adoptive
transfer experiments suggest that the cells that required the
IL-18R and MyD88 are either not in the LN at the time of
transfer or that the ones that are present have not been
sensitized. Previous studies evaluating antigen presentation in
MyD88/ mice have demonstrated that MyD88 is required
for cross-presentation of a heat shock fusion protein in a
TLR4-independent manner (Palliser et al., 2004). Conversely,
MyD88-dependent cross-presentation was dependent on
TLR4 and LPS in a system that used ovalbumin (Burgdorf
et al., 2008) Inasmuch as our studies also indicate that CHS is
MyD88-dependent and TLR4-independent, a role for cross-
presentation in the CHS response cannot be excluded. Taken
together, these results suggest that the MyD88-dependent
defect lies in the antigen presentation process.
Dendritic epidermal T cells are another group of skin-
resident immune cells that may be involved in the MyD88-
dependent responses in CHS. The majority of dendritic
epidermal T cells are host derived after BM transplant
(Hayakawa et al., 1996). However, C57BL/6 mice deficient
in the delta chain of the TCR have no defect in the CHS
response to DNFB (Girardi et al., 2002). Therefore, loss of
MyD88 or the IL-18R in the dendritic epidermal T cells is not
likely to have a role in the defect in the CHS response that we
observed.
By contrast to MyD88 and IL-18R, IL-1R is required in a
radiosensitive cell in the CHS response. The IL-1R is
expressed on several radiosensitive cells involved in the
CHS response, including monocytes, macrophages, and T
and B cells (Sims et al., 1988; Wang et al., 1999). IL-1a
and IL-1b are required for T-cell activation during the
sensitization phase, and for cytokine production and recruit-
ment of inflammatory cells during the elicitation phase
(Shornick et al., 1996; Nakae et al., 2001, 2003). Thus, it is
likely that the deficiency of the IL-1R on T cells is responsible
for the defect in the CHS response in the IL-1R/ mice.
Surprisingly, our results suggest that MyD88 is not
required downstream of the IL-1R in the CHS response. The
ability of MyD88/ BM cells to reconstitute a WT mouse
and support a CHS response demonstrate that MyD88 is not
required in the radiosensitive, BM-derived lymphocytes,
whereas the IL-1R is required on radiosensitive, BM-derived
lymphocytes. Signaling downstream of the IL-1R in several
cell types, including the EL-4 thymoma cell line, results in
activation of at least two signaling pathways. One pathway
involves MyD88 and the other results in activation of
PI3-kinase, phosphorylation of protein kinase B, and activa-
tion of NF-kB (Reddy et al. 1997; Adachi et al. 1998;
Neumann et al. 2002 and Davis et al., 2006). In addition, IL-
1b has been shown to have a MyD88-independent role in the
adjuvant effect of alum (Eisenbarth et al., 2008). Our results
suggest that either of these pathways may be used in BM-
derived cells during the CHS response.
Epidermal LCs express the IL-1R and migrate to skin-
draining LNs in response to IL-1b during the sensitization
phase of the CHS response (Cumberbatch et al., 1997, 1998).
These cells are also radioresistant and this may seem to
contradict with our findings that the IL-1R is required on a
radiosensitive cell. However, the role of epidermal LCs in the
CHS response is controversial, and our results are consistent
with no role for the epidermal LCs in the sensitization phase
of the CHS response (Merad et al., 2008).
In summary, our results demonstrate that the CHS
response is MyD88, IL-1, and IL-18 dependent. The IL-1R is
required in radiosensitive, BM-derived lymphocytes during
the sensitization phase of the CHS response. In contrast, both
MyD88 and the IL-18R are required in radioresistant cells
during the sensitization phase of the CHS response. Taken
together these results suggest that methods targeting the IL-
1R, IL-18R, and/or MyD88 will be useful in inhibiting the
sensitization phase of allergic contact dermatitis.
MATERIALS AND METHODS
Mice
C57BL/6 mice (6- to 8-week-old) were purchased from the National
Cancer Institute. MyD88/ (Adachi et al., 1998), TLR4/ (Hoshino
et al., 1999), TLR6/ (Takeuchi et al., 2001), and TLR9/ (Hemmi
et al., 2000) mice were originally generated by Dr Shizuo Akira’s
group and generously provided by Dr Akira through the laboratory of
Dr Marco Colonna (Washington University, St Louis, MO). B6.SJL-
Ptprca (CD45.1, Ly5.1), TLR2/, IL-1R/, and IL-18R/ mice
were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice
were maintained under specific pathogen-free conditions and used
after 8 weeks of age. Animal studies were approved by the Animal
Studies Committee at Washington University.
Contact hypersensitivity
The CHS experiments were performed using a standard protocol
(Gaspari and Katz, 1993). DNFB, olive oil, and acetone were
obtained from Sigma-Aldrich, (St Louis, MO). Briefly, mice were
sensitized by application of 25 ml  2 of 0.5% DNFB in acetone:
olive oil (4:1 v/v) on their shaved abdomen on days 0 and 1. At day
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5, the mice were challenged with 10 ml of 0.2% DNFB in
acetone:olive oil (4:1) on each side of both ears. Ear thickness was
measured before challenge and 24 hours after challenge using a
micrometer (Hahn & Kold, Stuttgart, Germany). As a control, mice
were either left naı¨ve or sensitized on the abdomen using vehicle on
days 0 and 1. On day 5, these mice were challenged with 0.2%
DNFB, and the ear thickness was measured 24 hours later. Hapten-
specific ear swelling was determined by measuring the degree of ear
swelling in the DNFB-sensitized, DNFB-challenged mice compared
with the vehicle-treated, DNFB-challenged mice.
BM chimeras
Bone marrow chimeras were created as described previously
(Tripathy et al., 2008). Briefly, host mice were irradiated with
9.5 Gy and then injected through tail vein with 1 107 BM cells
isolated from the femora and tibiae of donor mice. The mice were
allowed to reconstitute for a minimum of 6 weeks before being
evaluated with the CHS protocol.
Adoptive transfers
Donor mice were sensitized with 0.5% DNFB on days 0 and 1. On
day 5, the LN cells were taken from the inguinal, axillary, and
brachial LNs of donor mice, pooled, and 1 107 cells were injected
through tail vein into naı¨ve recipient mice. Immediately after
injection, the mice were challenged with 0.2% DNFB and hapten-
specific ear swelling was determined 24 hours later, as described
above. In parallel, LN cells from naı¨ve mice were injected into naı¨ve
recipient mice. These mice were also challenged with 0.2% DNFB,
and they served as negative controls.
Dendritic cells
Skin-draining LNs (inguinal, axillary, and brachial) were dissected
from each mouse and digested in 1 mg ml1 collagenase D (Roche
Diagnostics, Indianapolis, IN) for 30 minutes at 37 1C with gentle
shaking. The LNs were then disrupted using a 70mm filter, washed
twice, and analyzed by flow cytometry.
FACS analysis
FACS analysis of single cell suspensions was performed using a FACS
Canto flow cytometer (BD Biosciences, San Jose, CA) for data
acquisition and FlowJo software (Tree Star, Ashland, OR). The
following antibodies were obtained from BD Biosciences: PE-
CD11c (clones N418 or HL3), FITC- or APC-CD86 (clone GL1).
Alexa fluor 700-IA/IE (pan-MHC-II, clone M5/114) was obtained
from eBiosciences (San Diego, CA). To block nonspecific binding of
antibodies to Fc receptors, all antibodies were diluted in the
presence of mAb 2.4G2 (Fc II/III receptor; American Type Culture
Collection, Manassas, VA).
Statistical analysis
Statistical analysis was performed using Prizm software (GraphPad,
La Jolla, CA). The statistical significance of the differences between
the means was determined by applying the unpaired, two-tailed
Student’s t-test. A difference was considered statistically significant
at Po0.05.
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